Quantification of amyloid PET for future clinical use: a state-of-the-art review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quantification of amyloid PET for future clinical use: a state-of-the-art review
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-04-07
DOI
10.1007/s00259-022-05784-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDEAS and New IDEAS: Amyloid PET in diverse populations
- (2022) Charles Windon et al. Alzheimers & Dementia
- Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
- (2022) Willemijn J. Jansen et al. JAMA Neurology
- Relationship between amyloid and tau levels and its impact on tau spreading
- (2021) Vincent Doré et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study
- (2021) Hugh G. Pemberton et al. EUROPEAN RADIOLOGY
- Molecular Imaging Approaches in Dementia
- (2021) Victor L. Villemagne et al. RADIOLOGY
- Advances in Brain Amyloid Imaging
- (2021) Natasha Krishnadas et al. SEMINARS IN NUCLEAR MEDICINE
- Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study
- (2021) Hiroshi Matsuda et al. Frontiers in Neurology
- Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum
- (2021) Gemma Salvadó et al. Alzheimers & Dementia
- Visual assessment of [18F]flutemetamol PET images can detect early amyloid pathology and grade its extent
- (2021) Lyduine E. Collij et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Towards a Universal Readout for Fluorine-18 Labelled Amyloid Tracers: The CAPTAINs Study
- (2021) Gerard N. Bischof et al. JOURNAL OF NUCLEAR MEDICINE
- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome
- (2021) Matthew D. Zammit et al. NEUROIMAGE
- Donanemab in Early Alzheimer’s Disease
- (2021) Mark A. Mintun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Centiloid scale analysis for 18F-THK5351 PET imaging in Alzheimer’s disease
- (2021) Tensho Yamao et al. Physica Medica-European Journal of Medical Physics
- Amyloid burden quantification depends on PET and MR image processing methodology
- (2021) Guilherme D. Kolinger et al. PLoS One
- AMYQ: An index to standardize quantitative amyloid load across PET tracers
- (2021) Jordi Pegueroles et al. Alzheimers & Dementia
- Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
- (2021) Silvia Ingala et al. Alzheimers & Dementia
- A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [18F]flutemetamol amyloid PET images
- (2021) Marco Bucci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders
- (2021) Adam J. Schwarz Neurotherapeutics
- Early detection of amyloid load using 18F-florbetaben PET
- (2021) Santiago Bullich et al. Alzheimers Research & Therapy
- Strategies to reduce sample sizes in Alzheimer’s disease primary and secondary prevention trials using longitudinal amyloid PET imaging
- (2021) Isadora Lopes Alves et al. Alzheimers Research & Therapy
- Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach
- (2021) Sarah K. Royse et al. Alzheimers Research & Therapy
- Aducanumab produced a clinically meaningful benefit in association with amyloid lowering
- (2021) Jeffrey Cummings et al. Alzheimers Research & Therapy
- Aducanumab: Appropriate use recommendations
- (2021) Jeffrey Cummings et al. Alzheimers & Dementia
- Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
- (2021) Bruno Dubois et al. LANCET NEUROLOGY
- A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease
- (2021) Stephen Salloway et al. NATURE MEDICINE
- Parametric imaging of dual-time window [18F]flutemetamol and [18F]florbetaben studies
- (2021) Fiona Heeman et al. NEUROIMAGE
- Technical and clinical validation of commercial automated volumetric MRI tools for dementia diagnosis—a systematic review
- (2021) Hugh G. Pemberton et al. NEURORADIOLOGY
- Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile
- (2021) Marta Milà-Alomà et al. Alzheimers Research & Therapy
- Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease
- (2021) Rik Ossenkoppele et al. JAMA Neurology
- Deep learning-based amyloid PET positivity classification model in the Alzheimer’s disease continuum by using 2-[18F]FDG PET
- (2021) Suhong Kim et al. EJNMMI Research
- Amyloid PET in the diagnostic workup of neurodegenerative disease
- (2021) Pierpaolo Alongi et al. Clinical and Translational Imaging
- Evaluating robustness of the Centiloid scale against variations in amyloid PET image resolution
- (2021) Mahnaz Shekari et al. Alzheimers & Dementia
- rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data
- (2021) Leonardo Iaccarino et al. NEUROIMAGE
- Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis
- (2021) Stefan J. Teipel et al. Frontiers in Aging Neuroscience
- Normative brain volume reports may improve differential diagnosis of dementing neurodegenerative diseases in clinical practice
- (2020) Dennis M. Hedderich et al. EUROPEAN RADIOLOGY
- Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer’s disease
- (2020) Sanka Amadoru et al. Alzheimers Research & Therapy
- Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study
- (2020) Isadora Lopes Alves et al. Alzheimers & Dementia
- Hippocampal Sclerosis Detection with NeuroQuant Compared with Neuroradiologists
- (2020) S. Louis et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer’s disease
- (2020) Min Seok Baek et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Repeatability of parametric methods for [18F]florbetapir imaging in Alzheimer’s disease and healthy controls: A test–retest study
- (2020) Sander CJ Verfaillie et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Simulating the effect of cerebral blood flow changes on regional quantification of [18F]flutemetamol and [18F]florbetaben studies
- (2020) Fiona Heeman et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Quantifying eloquent locations for glioblastoma surgery using resection probability maps
- (2020) Domenique M. J. Müller et al. JOURNAL OF NEUROSURGERY
- Defining a Centiloid scale threshold predicting long-term progression to dementia in patients attending the memory clinic: an [18F] flutemetamol amyloid PET study
- (2020) Bernard J. Hanseeuw et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical evaluation of automated quantitative MRI reports for assessment of hippocampal sclerosis
- (2020) Olivia Goodkin et al. EUROPEAN RADIOLOGY
- Multi-tracer model for staging cortical amyloid deposition using PET imaging
- (2020) Lyduine E. Collij et al. NEUROLOGY
- Derivation and utility of an Aβ-PET pathology accumulation index to estimate Aβ load
- (2020) Antoine Leuzy et al. NEUROLOGY
- Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid
- (2020) Soo Hyun Cho et al. Scientific Reports
- PET amyloid in normal aging: direct comparison of visual and automatic processing methods
- (2020) Sven Haller et al. Scientific Reports
- Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment
- (2020) David S. Knopman et al. JAMA Neurology
- Overview of dominantly inherited AD and top‐line DIAN‐TU results of solanezumab and gantenerumab
- (2020) Randall J Bateman et al. Alzheimers & Dementia
- AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer’s disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial)
- (2020) Paul S. Aisen et al. Alzheimers & Dementia
- Harmonization of amyloid PET scans minimizes the impact of reconstruction parameters on centiloid values
- (2020) Mahnaz Shekari et al. Alzheimers & Dementia
- Converging evidence for a “gray‐zone” of amyloid burden and its relevance
- (2020) Santiago Bullich et al. Alzheimers & Dementia
- Emerge and Engage topline results: Phase 3 studies of aducanumab in early Alzheimer’s disease
- (2020) Samantha Budd Haeberlein et al. Alzheimers & Dementia
- Interim positron emission tomography in diffuse large B-cell lymphoma
- (2020) Lars Kurch et al. JOURNAL OF NUCLEAR MEDICINE
- Defining the Lowest Threshold for Amyloid-PET to Predict Future Cognitive Decline and Amyloid Accumulation
- (2020) Michelle E. Farrell et al. NEUROLOGY
- Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?
- (2020) Barbara Paghera et al. QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies
- (2020) Pierrick Bourgeat et al. NEUROIMAGE
- Optimized dual-time-window protocols for quantitative [18F]flutemetamol and [18F]florbetaben PET studies
- (2019) Fiona Heeman et al. EJNMMI Research
- Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
- (2019) Gemma Salvadó et al. Alzheimers Research & Therapy
- ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes
- (2019) Anja Soldan et al. NEUROLOGY
- Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis
- (2019) Antoine Leuzy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Improved Detection of Subtle Mesial Temporal Sclerosis: Validation of a Commercially Available Software for Automated Segmentation of Hippocampal Volume
- (2019) J.M. Mettenburg et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Comparison of 18F-florbetaben quantification results using the standard Centiloid, MR-based, and MR-less CapAIBL® approaches: Validation against histopathology
- (2019) Vincent Doré et al. Alzheimers & Dementia
- Quantitative evaluation of beta-amyloid brain PET imaging in dementia: a comparison between two commercial software packages and the clinical report
- (2019) Sorcha Curry et al. BRITISH JOURNAL OF RADIOLOGY
- Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
- (2019) Gil D. Rabinovici et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Subthreshold amyloid and its biological and clinical meaning
- (2019) Gérard N. Bischof et al. NEUROLOGY
- Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
- (2019) Clifford R. Jack et al. JAMA Neurology
- Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography
- (2019) Niklas Mattsson et al. JAMA Neurology
- Voxel-based statistical analysis and quantification of amyloid PET in the Japanese Alzheimer’s disease neuroimaging initiative (J-ADNI) multi-center study
- (2019) Go Akamatsu et al. EJNMMI Research
- Applying the ATN scheme in a memory clinic population
- (2019) Daniele Altomare et al. NEUROLOGY
- Hippocampal profiling: Localized magnetic resonance imaging volumetry and T2 relaxometry for hippocampal sclerosis
- (2019) Sjoerd B. Vos et al. EPILEPSIA
- The A/T/N model applied through imaging biomarkers in a memory clinic
- (2019) Alessandra Dodich et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB
- (2019) Soo Hyun Cho et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The Spatial-Temporal Ordering of Amyloid Pathology and Opportunities for PET Imaging
- (2019) Enrico Fantoni et al. JOURNAL OF NUCLEAR MEDICINE
- Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
- (2019) Gregory Klein et al. Alzheimers Research & Therapy
- Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the Centiloid scale
- (2018) Michael Navitsky et al. Alzheimers & Dementia
- Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET
- (2018) Daniele Altomare et al. Alzheimers & Dementia
- Added value of 18 F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study
- (2018) Mathieu Ceccaldi et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer’s Disease
- (2018) Enrico R. Fantoni et al. JOURNAL OF ALZHEIMERS DISEASE
- Amsterdam Dementia Cohort: Performing Research to Optimize Care
- (2018) Wiesje M. van der Flier et al. JOURNAL OF ALZHEIMERS DISEASE
- A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer’s Disease (REMEMBER)
- (2018) Ellis Niemantsverdriet et al. JOURNAL OF ALZHEIMERS DISEASE
- Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template
- (2018) Johan Lilja et al. JOURNAL OF NUCLEAR MEDICINE
- Predicted sequence of cortical tau and amyloid-β deposition in Alzheimer disease spectrum
- (2018) Hanna Cho et al. NEUROBIOLOGY OF AGING
- Amyloid “accumulators”
- (2018) Corey T. McMillan et al. NEUROLOGY
- Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
- (2018) Lawrence S. Honig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
- (2018) Christopher G. Schwarz et al. Scientific Reports
- Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
- (2018) Arno de Wilde et al. JAMA Neurology
- Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
- (2018) Yi Su et al. NeuroImage-Clinical
- Optimizing Regions-of-Interest Composites for Capturing Treatment Effects on Brain Amyloid in Clinical Trials
- (2018) Volha Tryputsen et al. JOURNAL OF ALZHEIMERS DISEASE
- Amyloid Load – a more sensitive biomarker for amyloid imaging
- (2018) Alex Whittington et al. JOURNAL OF NUCLEAR MEDICINE
- Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL
- (2018) Pierrick Bourgeat et al. NEUROIMAGE
- Automatic normative quantification of brain tissue volume to support the diagnosis of dementia: A clinical evaluation of diagnostic accuracy
- (2018) Meike W. Vernooij et al. NeuroImage-Clinical
- Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology
- (2018) Renaud La Joie et al. Alzheimers & Dementia
- AMYPAD Diagnostic and Patient Management Study: Rationale and design
- (2018) Giovanni B. Frisoni et al. Alzheimers & Dementia
- A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
- (2018) Christopher G. Schwarz et al. JOURNAL OF ALZHEIMERS DISEASE
- Assessing Amyloid Pathology in Cognitively Normal Subjects using [18F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods
- (2018) Lyduine Collij et al. JOURNAL OF NUCLEAR MEDICINE
- Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults
- (2018) Michelle E. Farrell et al. NEUROLOGY
- Centiloid scaling for quantification of brain amyloid with [18F]flutemetamol using multiple processing methods
- (2018) Mark R. Battle et al. EJNMMI Research
- Stroke severity quantification by critical care physicians in a mobile stroke unit
- (2017) Maren R. Hov et al. European Journal of Emergency Medicine
- 18F-Florbetaben PET beta-amyloid binding expressed in Centiloids
- (2017) Christopher C. Rowe et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
- (2017) Michael J. Pontecorvo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Spatiotemporal Distribution of β-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities
- (2017) Alex Whittington et al. JOURNAL OF NUCLEAR MEDICINE
- Forward to the Past: The Case for Quantitative PET Imaging
- (2017) Adriaan A. Lammertsma JOURNAL OF NUCLEAR MEDICINE
- Validation of Noninvasive Tracer Kinetic Analysis of18F-Florbetaben PET Using a Dual–Time-Window Acquisition Protocol
- (2017) Santiago Bullich et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical Use and Utility of Amyloid Imaging
- (2017) Henryk Barthel et al. JOURNAL OF NUCLEAR MEDICINE
- Optimal Reference Region to Measure Longitudinal Amyloid-β Change with 18 F-Florbetaben PET
- (2017) Santiago Bullich et al. JOURNAL OF NUCLEAR MEDICINE
- Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50–95 years: a cross-sectional study
- (2017) Clifford R Jack et al. LANCET NEUROLOGY
- Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework
- (2017) Konstantinos Chiotis et al. NEUROBIOLOGY OF AGING
- NiftyPET: a High-throughput Software Platform for High Quantitative Accuracy and Precision PET Imaging and Analysis
- (2017) Pawel J. Markiewicz et al. NEUROINFORMATICS
- Amyloid PET scan
- (2017) Gaël Chételat et al. NEUROLOGY
- A phase 3 trial of IV immunoglobulin for Alzheimer disease
- (2017) Norman R. Relkin et al. NEUROLOGY
- In vivo staging of regional amyloid deposition
- (2017) Michel J. Grothe et al. NEUROLOGY
- Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol β-amyloid PET brain images
- (2017) Christopher J. Buckley et al. NUCLEAR MEDICINE COMMUNICATIONS
- Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
- (2017) Sebastian Palmqvist et al. Nature Communications
- Centiloid method evaluation for amyloid PET of subcortical vascular dementia
- (2017) Hyuk Jin Yun et al. Scientific Reports
- Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer’s disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database
- (2017) Fayçal Ben Bouallègue et al. Alzheimers Research & Therapy
- A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
- (2017) Susanne Ostrowitzki et al. Alzheimers Research & Therapy
- Diagnostic impact of [18F]flutemetamol PET in early-onset dementia
- (2017) Marissa D. Zwan et al. Alzheimers Research & Therapy
- Optimized classification of 18 F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment
- (2017) Santiago Bullich et al. NeuroImage-Clinical
- In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum
- (2016) Hanna Cho et al. ANNALS OF NEUROLOGY
- Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro
- (2016) Woo Hee Choi et al. ANNALS OF NUCLEAR MEDICINE
- Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study
- (2016) Antoine Leuzy et al. BRAIN
- Effect of Amyloid Imaging on the Diagnosis and Management of Patients with Cognitive Decline: Impact of Appropriate Use Criteria
- (2016) Michael Grundman et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Inter-rater variability of visual interpretation and comparison with quantitative evaluation of 11C-PiB PET amyloid images of the Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI) multicenter study
- (2016) Tomohiko Yamane et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis
- (2016) Andrea Chincarini et al. JOURNAL OF ALZHEIMERS DISEASE
- Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth
- (2016) J. Lilja et al. JOURNAL OF NUCLEAR MEDICINE
- Standardized Expression of 18F-NAV4694 and 11C-PiB -Amyloid PET Results with the Centiloid Scale
- (2016) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study
- (2016) J. Seibyl et al. JOURNAL OF NUCLEAR MEDICINE
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers
- (2016) Clifford R. Jack et al. NEUROLOGY
- Reliable measurements of brain atrophy in individual patients with multiple sclerosis
- (2016) Dirk Smeets et al. Brain and Behavior
- The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
- (2015) William J. Jagust et al. Alzheimers & Dementia
- The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
- (2015) William E. Klunk et al. Alzheimers & Dementia
- Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: Phase 3 study
- (2015) Osama Sabri et al. Alzheimers & Dementia
- The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
- (2015) Mark E. Schmidt et al. Alzheimers & Dementia
- Is amyloid-β harmful to the brain? Insights from human imaging studies
- (2015) William Jagust BRAIN
- Prevalence of Amyloid PET Positivity in Dementia Syndromes
- (2015) Rik Ossenkoppele et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio
- (2015) Zsolt Cselényi et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Man Versus Machine Part 2: Comparison of Radiologists’ Interpretations and NeuroQuant Measures of Brain Asymmetry and Progressive Atrophy in Patients With Traumatic Brain Injury
- (2015) David E. Ross et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- 18F-Florbetapir PET in Patients with Frontotemporal Dementia and Alzheimer Disease
- (2015) C. Kobylecki et al. JOURNAL OF NUCLEAR MEDICINE
- Measurement of Longitudinal -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios
- (2015) S. M. Landau et al. JOURNAL OF NUCLEAR MEDICINE
- Partial volume correction in quantitative amyloid imaging
- (2015) Yi Su et al. NEUROIMAGE
- Recommendations from the Italian Interdisciplinary Working Group (AIMN, AIP, SINDEM) for the utilization of amyloid imaging in clinical practice
- (2015) Ugo Paolo Guerra et al. NEUROLOGICAL SCIENCES
- Amyloid-β11C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
- (2015) Enchi Liu et al. NEUROLOGY
- Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes
- (2015) Stefanie Schreiber et al. JAMA Neurology
- COMPARISON OF [18F] FLUTEMETAMOL AND [11C] PIB PET IMAGES
- (2014) Suzuka Ataka et al. Alzheimers & Dementia
- Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers
- (2014) S. M. Landau et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Automated Quantification of 18F-Flutemetamol PET Activity for Categorizing Scans as Negative or Positive for Brain Amyloid: Concordance with Visual Image Reads
- (2014) L. Thurfjell et al. JOURNAL OF NUCLEAR MEDICINE
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
- (2014) Stephen Salloway et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
- (2014) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
- (2014) Perani Daniela et al. Biomed Research International
- Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
- (2014) Niklas Mattsson et al. Annals of Clinical and Translational Neurology
- Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
- (2013) Keith A. Johnson et al. Alzheimers & Dementia
- Man Versus Machine: Comparison of Radiologists’ Interpretations and NeuroQuant®Volumetric Analyses of Brain MRIs in Patients With Traumatic Brain Injury
- (2013) David E. Ross et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for -Amyloid Imaging in Aging and Dementia
- (2013) C. C. Rowe et al. JOURNAL OF NUCLEAR MEDICINE
- Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
- (2013) Clifford R Jack et al. LANCET NEUROLOGY
- Impact of18F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making
- (2013) Anthony S. Zannas et al. NEUROCASE
- Classification of amyloid-positivity in controls: Comparison of visual read and quantitative approaches
- (2013) Ann D. Cohen et al. NEUROIMAGE
- A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
- (2013) Rachelle S. Doody et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resection Probability Maps for Quality Assessment of Glioma Surgery without Brain Location Bias
- (2013) Philip C. De Witt Hamer et al. PLoS One
- [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies
- (2012) Juha O. Rinne et al. ACTA NEUROPATHOLOGICA
- Impact of Beta-Amyloid-Specific Florbetaben PET Imaging on Confidence in Early Diagnosis of Alzheimer’s Disease
- (2012) C.G. Schipke et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
- (2012) V. Camus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer’s disease
- (2012) Victor L. Villemagne et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects
- (2012) A. D. Joshi et al. JOURNAL OF NUCLEAR MEDICINE
- Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
- (2012) Christopher M Clark et al. LANCET NEUROLOGY
- Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
- (2012) Adam S. Fleisher et al. NEUROBIOLOGY OF AGING
- Using Positron Emission Tomography and Florbetapir F 18 to Image Cortical Amyloid in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer Disease
- (2011) Adam S. Fleisher ARCHIVES OF NEUROLOGY
- The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
- (2010) William J. Jagust et al. Alzheimers & Dementia
- 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial
- (2010) Rik Vandenberghe et al. ANNALS OF NEUROLOGY
- Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography
- (2010) David J. Brooks MOVEMENT DISORDERS
- Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy
- (2010) Paul E. Kinahan et al. SEMINARS IN ULTRASOUND CT AND MRI
- The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
- (2009) Kathryn A Ellis et al. INTERNATIONAL PSYCHOGERIATRICS
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
- (2008) E. C. Mormino et al. BRAIN
- Imaging amyloid deposition in Lewy body diseases
- (2008) S. N. Gomperts et al. NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started